Aims Erythropoietin (EPO)-deficient anaemia has been described in Type 1 diabetic patients with both severe autonomic neuropathy (AN) and proteinuria. This study was aimed at distinguishing between the effects of AN and nephropathy on haemoglobin and EPO levels in Type 2 diabetic patients at an early stage of diabetic nephropathy.
Introduction
Erythropoietin (EPO), the principal regulator of erythropoiesis [1] , is produced by the peritubular fibroblast-like interstitial cells of the renal cortex in response to tissue hypoxia [2] [3] [4] .
Typically, there is an inverse log / linear relationship between EPO levels and haemoglobin (Hb) concentration or haematocrit (Ht) [1] .
In addition to the known neural control of renal circulation and tubular function [5] , experimental data also support a role for renal sympathetic innervation in the regulation of EPO production [6, 7] , although its clinical relevance is unclear [2] . Anaemia with a relative deficit of EPO has been observed in patients with dysautonomias [8] [9] [10] and in some Type 1 diabetic patients with both severe autonomic neuropathy (AN) and proteinuria [11] [12] [13] [14] . However, at an advanced stage of diabetic nephropathy the common coexistence of AN makes it difficult to distinguish the respective roles of kidney damage and autonomic dysfunction in EPO deficit. Reports in this field in Type 2 diabetes are rare and inconclusive [15] [16] [17] [18] . Moreover, in those studies the lack of any assessment of autonomic function and the inclusion of patients with advanced diabetic nephropathy or with subnormal creatinine clearance made any conclusions on the impact of autonomic dysfunction on EPO regulation impossible [15] [16] [17] [18] . Furthermore, the substantial heterogeneity of the morphological lesions of diabetic nephropathy in Type 2 diabetes [19] makes a simple extrapolation of data from Type 1 to Type 2 diabetes unreliable.
Thus, this study was aimed at identifying the possible impact on Hb levels and on EPO regulation of autonomic dysfunction and nephropathy in Type 2 diabetic patients at an early stage of diabetic nephropathy, by excluding those with overt nephropathy and by accurate assessment of cardiac autonomic function.
Patients and methods

Neurological assessment
Autonomic function was assessed by four cardiovascular tests (deep breathing, lying to standing, Valsalva manoeuvre and postural hypotension) that were performed according to standard procedure [20] and evaluated using age-related reference values [21] . An autonomic score was obtained from the sum of scores given to each of the four tests (0 for a normal result, 1 for a borderline result, and 2 for an abnormal result) [21, 22] . Type 2 diabetic patients were divided according to the autonomic tests results into two groups with AN (one or more abnormal tests) and without AN (less than one abnormal test).
BP monitoring and urinary measurement
Non-invasive 24-h ambulatory blood pressure (BP) monitoring (ABPM) was performed using an oscillometric recorder (SpaceLabs 90207, Redmond, WA, USA) [23] . The device was programmed to measure BP every 20 min for 24 h. Systolic and diastolic BP measurements were averaged for the day and the night periods, according to the patients' reported time of waking up and going to bed. In addition, the percentage change from day to night in BP ( ∆ day-night) was calculated as: (day BP − night BP) × 100/day BP.
Albumin concentration was measured by a double antibody radioimmunoassay (Albumin RIA 100; Pharmacia AB, Uppsala, Sweden) on the timed day and overnight urine collections. Urinary albumin excretion (UAE) was calculated for the day and the night periods, and for the 24-h period. In addition, the percentage change from day to night in UAE ( ∆ day-night) was calculated.
Evaluation of haematological parameters
EPO levels were measured on morning serum samples by an enzyme-linked immunosorbent assay based on the doubleantibody sandwich method (Quantikine IVD Epo ELISA; R&D Systems, Inc., Minneapolis, MN, USA). Serum EPO normal range was 3.3 -16.6 mIU/ml. Full blood count, serum iron, ferritin, vitamin B 12 , folate concentrations, and thyroid hormones were also measured, these latter in order to exclude previously unknown causes of anaemia (iron or vitamin deficiency, hypothyroidism). Finally, serum creatinine and erythrocyte sedimentation rate (ESR) were measured.
Presence of non-proliferative or proliferative retinopathy was determined by ophthalmoscopic examination.
Patients
Sixty-four subjects with Type 2 diabetes were consecutively recruited at the diabetic clinic of the University of Rome 'Tor Vergata'. Inclusion criteria were age < 70 years and a urinary albumin concentration on three early morning urine collections in the range of normo-or microalbuminuria (0-200 mg/l). Exclusion criteria were macroalbuminuria (urinary albumin concentration > 200 mg/l), impaired renal function (serum creatinine > 115 µ mol / l or creatinine clearance < 70 ml min ), urinary infection, significant abnormality of hepatic, haematopoietic, respiratory or endocrine function, known causes of anaemia or EPO deficit, chronic infectious disorders or active foot ulcers, cerebrovascular or coronary heart disease, arrhythmia, and any other condition or drug affecting autonomic nervous function other than hypertension or antihypertensive agents. The study was approved by the Ethics Committee of Tor Vergata University and informed consent was obtained from all participants.
Mean age was 52.1 years (range 26 -68) and the mean duration of diabetes was 10.2 years (range 0.2 -35). Forty patients were men and 24 women. Mean body mass index (BMI) was 27.5 kg /m 2 (range 17.1-35.7). Seven patients (10.9%) were treated with diet, 40 (62.5%) with oral agents (sulphonylureas and /or metformin), seven with oral agents and insulin (10.9%), and 10 (15.6%) with insulin alone. Fifteen patients (23.4%) had a diagnosis of hypertension according to the World Health Organization (casual BP > 140/90 mmHg) and 12 of these were under treatment with ACE inhibitors ( n = 6), angiotensin receptor inhibitors and calcium channel antagonists ( n = 2), or calcium channel antagonists alone ( n = 3). One patient was treated with a low dose of hydrochlorothiazide in addition to ACE inhibitors.
Assuming the presence of anaemia for Hb ≤ 11.5 g /dl in women and ≤ 12 g/dl in men, we used as control group for haematological parameters 42 non-anaemic subjects (23 males and 19 females, mean age 44.4 years, range 17-64 years, Hb 14.01 mg /dl, range 11.7-16.5 mg /dl).
Statistical analysis
Data are expressed as mean ± SD . Unpaired Student's t -test was used as test of significance for means in the case of variables showing normal distribution, and the χ 2 test was used for categorical variables. The Mann-Whitney U -test was used for EPO and UAE values that did not satisfy the assumption of a normal distribution. Linear regression analysis was used to relate different variables. Logarithmic transformation was applied to UAE (decimal logarithm) and EPO (natural logarithm), nonparametric variables, before using linear regression analysis. Multiple linear regression analyses were performed to determine the relative contribution to the variability of Hb and Ht of different independent variables. The relationship between EPO and Hb was assessed by regression of ln EPO on Hb. The slopes of the regression lines obtained in the control group and in Type 2 diabetic patients were compared using t -test. All statistical analyses were done using the program StatView IV (SAS Institute Inc., Cary, NC, USA). A value of 2 P < 0.05 was considered significant.
Results
Autonomic neuropathy assessment
Among those with Type 2 diabetes 24 had AN and 40 did not. There were no differences between Type 2 patients with and without AN in clinical parameters, apart from the presence of a slightly higher serum creatinine level, largely in the normal range (67.2 ± 15.03 µ mol / l), and a higher percentage of retinopathy in the group with AN (Table 1) . Three subjects, all in the group with AN, had abnormal values of postural hypotension ( ≥ 30 mmHg), five patients, including one without AN (who was taking diuretics), showed borderline values (between 20 and 30 mmHg).
BP monitoring and urinary measurement
ABPM displayed lower values of ∆ day-night in systolic and diastolic BP in Type 2 diabetic patients with AN than in those without AN (Table 2 ). No differences were observed between the two groups for day, night, and 24-h UAE, but a lower ∆ daynight in UAE was present in the patients with AN (Table 2) .
Haematological evaluation
When comparing diabetic individuals with and without AN, no differences were present for any haematological parameter, and values were within the normal range (Table 3) . Defining anaemia as Hb ≤ 11.5 g / dl in women and ≤ 12 g /dl in men, we did not find any anaemia in diabetic patients, but 11 out of 64 had Hb < 13 g / dl. Comparison between individuals with Hb > 13 g /dl and those with Hb < 13 g /dl (Table 4) showed significant differences in BMI , in ferritin and in ESR. Interestingly, all the cardiovascular tests and autonomic score were lower in those with Hb < 13 g / dl. The presence of Hb < 13 g / dl was associated with female gender ( χ 2 = 11.1, P < 0.001), with the presence of AN ( χ 2 = 3.9, P < 0.05) and postural hypotension ( χ 2 = 7.8, P < 0.05). The presence of Hb > 13 g /dl was associated with the status of actual smoker ( χ 2 = 4.2, P < 0.05) (Table 4) .
Moreover, patients with Hb < 13 g/dl displayed lower ∆ day-night in diastolic BP compared with those with Hb > 13 g /dl (7.9 ± 12.4 vs. 14.7 ± 8.6%, P < 0.05).
Relationship between autonomic function and haematological parameters
Using simple linear regression, haematocrit was related to postural hypotension ( r = − 0.30, P < 0.01), deep breathing (r = 0.25, P < 0.05), and autonomic score (r = −0.32, P < 0.01).
To investigate the independent effects of AN on haematocrit, we performed a multiple regression analysis adjusting for the other variables associated to Hb or related in simple regression analysis to haematocrit, i.e. gender, BMI, duration of diabetes, smoking, serum creatinine, 24-h UAE, 24-h diastolic BP, serum ferritin, and ESR (Table 5 ). With this model, that explained 58% of the variability of haematocrit (adjusted R 2 = 0.58), we found that autonomic score was independently related together with ESR and ferritin. Using the same model, we found that serum ferritin, ESR, and female gender were the only variables related to Hb (Table 5) . Haematocrit was also related in simple regression analysis to ∆ day-night in systolic (r = 0.30, P < 0.01) and diastolic BP, but the significance of the relationship disappeared after adjusting in multiple regression analysis for autonomic score and creatinine.
Relationship between Hb and EPO
Using linear regression analysis, we found a significant relationship between ln EPO and Hb in the control group of non-anaemic subjects [t = −2.40, degree of freedom = 40, Data are mean ± SD or median (range). t-Test *P < 0.05; **P < 0.01; ***P < 0.0001. χ 2 test †P < 0.05; † † †P < 0.001.
Table 4
Clinical parameters of Type 2 diabetic patients with haemoglobin (Hb) > 13 g /dl and < 13 g /dl P = 0.021; 95% confidence interval (CI) for slope −0.30, −0.02]. In contrast, no relationship was observed between ln EPO and Hb in Type 2 diabetic patients (t = −0.36, degree of freedom = 62, P = 0.721; 95% CI for slope −0.13, 0.09). We compared the slopes of the regression lines between ln EPO and Hb of the control and Type 2 diabetic subjects, −0.16 and −0.02, respectively, and found a significant difference between them (t = 14.4, degree of freedom = 102, P < 0.0001) (Fig. 1) . Moreover, EPO levels were no higher in diabetic patients with Hb < 13 g /dl than in those with Hb > 13 g /dl (Table 4) . The six patients using ACE inhibitors did not show any significant difference in haematological parameters compared with the others.
Discussion
This study demonstrates an independent link between AN and haematological parameters in Type 2 diabetes before the development of overt nephropathy. Although Type 2 diabetic patients with AN did not have reduced Hb and EPO levels, when dividing Type 2 diabetic patients according to Hb levels in two groups with Hb > 13 g / dl or < 13 g /dl, we observed in the group with lower Hb a greater prevalence of AN and a greater impairment in all cardiovascular tests. Furthermore, in multiple regression analysis only the autonomic score in addition to ESR and ferritin was independently related to haematocrit.
Type 2 diabetic patients with AN displayed the expected abnormalities in circadian rhythms of BP and albumin excretion, i.e. an impaired nocturnal fall [24 -26] . Haematocrit was related in univariate analysis to day-night change in BP. However, this did not persist after adjusting for autonomic score, suggesting that the link was mediated by AN. The association observed between diabetic retinopathy and AN has been attributed to the coexistence of late diabetes complications [27, 28] .
We appear to be the first to report in patients without overt nephropathy the loss of the physiological inverse relationship between EPO levels and Hb concentration. This has previously been reported, but at an advanced stage of nephropathy in patients with both proteinuria and severe autonomic impairment [13, 14, 29] . In the present study, the expected association between lower Hb (< 13 g /dl) and higher EPO levels was not present in the Type 2 diabetic group. Thus, this study points to a dysregulation of EPO production in Type 2 diabetes at an early stage of diabetic nephropathy before macroalbuminuria develops and renal function begins to decline.
Two recent studies in Type 1 diabetes have suggested that AN, when associated with proteinuria, acts as a promoter of EPO-deficient anaemia [29, 30] . Our study suggests that nephropathy is also not the only cause of EPO dysregulation in Type 2 diabetes. Given the specific features of diabetic nephropathy in Type 2 diabetes [19] , it is possible that tubulointerstitial lesions may contribute to impaired EPO production.
Despite the exclusion of patients with active foot ulcers or known infectious diseases, we found an independent relationship between ESR and Hb or Ht levels. This finding suggests an Figure 1 Relationship between the natural logarithm (ln) of serum erythropoietin (EPO) and haemoglobin (Hb) concentrations in 64 Type 2 diabetic patients (᭹) and in 42 non-diabetic non-anaemic control subjects (ᮀ). The slopes of the regression lines between ln EPO and haemoglobin of the control subjects (dotted line) and the Type 2 diabetic patients (solid line) were significantly different between them (P < 0.0001). No relationship was present at all in Type 2 diabetic patients.
inhibitory role for inflammatory cytokines in EPO production [31] . This is the first direct evidence of a link between haematological parameters and ESR.
The presence in multivariate analysis of a positive correlation between ferritin and Hb or Ht indicates the importance of iron stores in the maintenance of Hb [32] , although all patients had a normochromic normocytic blood profile with normal serum ferritin level.
A limitation of this study was the absence of overtly anaemic diabetic patients, in which an EPO deficit would have been more striking. This absence was probably due to the exclusion of individuals with macroalbuminuria, in which the prevalence of anaemia increases significantly [32] . At the stage of overt nephropathy the common coexistence of AN makes it difficult to separate the respective roles of AN and nephropathy on Hb and EPO levels. Notwithstanding the lack of anaemic patients, the loss of the physiological relationship between EPO and Hb levels points to abnormal EPO regulation developing before clinical nephropathy and the appearance of anaemia. The independent relationship in the whole Type 2 diabetic group between Ht and autonomic score supports a contributory role of the autonomic nervous system in the maintenance of haematological homeostasis and EPO regulation.
In conclusion, this study documents an early dysregulation of EPO production with the loss of the physiological relationship between Hb and EPO levels before the development of overt nephropathy in Type 2 diabetes. The significant association between Hb and AN points to a role of AN in early EPO dysregulation.
